A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?

Eur Urol. 2024 Mar;85(3):227-228. doi: 10.1016/j.eururo.2023.09.022. Epub 2023 Oct 11.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Male
  • Neoadjuvant Therapy* / adverse effects
  • Prostate-Specific Antigen
  • Prostatectomy
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / surgery

Substances

  • Prostate-Specific Antigen